Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 11 studies | 67% ± 23% | |
| retina horizontal cell | 6 studies | 53% ± 19% | |
| interneuron | 3 studies | 54% ± 16% | |
| retinal rod cell | 3 studies | 23% ± 5% | |
| granule cell | 3 studies | 38% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2212.06 | 2641 / 2642 | 98% | 24.65 | 688 / 705 |
| kidney | 73% | 1179.84 | 65 / 89 | 47% | 2.37 | 419 / 901 |
| skin | 59% | 122.88 | 1060 / 1809 | 2% | 0.09 | 8 / 472 |
| ovary | 17% | 45.32 | 31 / 180 | 16% | 0.43 | 70 / 430 |
| lung | 18% | 29.17 | 104 / 578 | 11% | 0.71 | 129 / 1155 |
| adrenal gland | 1% | 5.43 | 2 / 258 | 28% | 1.28 | 64 / 230 |
| stomach | 13% | 17.84 | 48 / 359 | 9% | 0.36 | 25 / 286 |
| spleen | 17% | 29.63 | 40 / 241 | 0% | 0 | 0 / 0 |
| uterus | 4% | 18.26 | 7 / 170 | 10% | 0.34 | 47 / 459 |
| thymus | 0% | 0.49 | 3 / 653 | 12% | 1.12 | 72 / 605 |
| prostate | 5% | 6.00 | 12 / 245 | 3% | 0.07 | 14 / 502 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.21 | 6 / 80 |
| pancreas | 1% | 0.99 | 3 / 328 | 6% | 0.22 | 11 / 178 |
| intestine | 1% | 1.78 | 11 / 966 | 6% | 0.15 | 31 / 527 |
| breast | 3% | 4.23 | 12 / 459 | 2% | 0.09 | 26 / 1118 |
| peripheral blood | 5% | 6.72 | 43 / 929 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 4% | 0.21 | 22 / 504 |
| esophagus | 1% | 1.00 | 11 / 1445 | 3% | 0.07 | 6 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
| adipose | 1% | 0.91 | 9 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.48 | 5 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
| heart | 0% | 0.25 | 2 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.16 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0034109 | Biological process | homotypic cell-cell adhesion |
| GO_0010842 | Biological process | retina layer formation |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MEGF11 |
| Protein name | Multiple EGF like domains 11 (Multiple epidermal growth factor-like domains protein 11) Multiple EGF like domains 11 Multiple epidermal growth factor-like domains protein 11 Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) |
| Synonyms | UNQ1949/PRO4432 KIAA1781 |
| Description | FUNCTION: May regulate the mosaic spacing of specific neuron subtypes in the retina through homotypic retinal neuron repulsion. Mosaics provide a mechanism to distribute each cell type evenly across the retina, ensuring that all parts of the visual field have access to a full set of processing elements (By similarity). . |
| Accessions | A0A0G2JN40 A0A087X003 H3BR81 C9JYE7 ENST00000614417.4 ENST00000455812.2 ENST00000615866.4 ENST00000395614.6 ENST00000564573.1 A6BM72 A0A0G2JMV8 ENST00000614717.1 ENST00000422354.6 [A6BM72-1] A0A087WT97 ENST00000490495.5 ENST00000409699.6 [A6BM72-1] ENST00000562154.5 A0A0G2JLW8 A0A0A0MS64 ENST00000288745.7 [A6BM72-2] ENST00000622356.1 |
